Citations

Clear

4847 citation(s) found for "Tu, Eric".

P2‐108: Lower scores in attention/executive functioning are associated with probable REM sleep behavior disorder among cognitively normal elderly subjects: The Mayo Clinic study of aging
Molano, Jennifer Rose V. , Roberts, Rosebud O., Ivnik, Robert J., Tangalos, Eric G., Cha, Ruth, Silber, Michael H. , Petersen, Ronald C. , Boeve, Bradley F. , Smith, Glenn E. , Ferman, Tanis J. , Geda, Yonas E. , Knopman, David S. , Pankratz, V. Shane

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_12 | Pages: No page available

10.1016/j.jalz.2008.05.1182 Get It

P2‐107: Anxiety and apathy are associated with probable REM sleep behavior disorder among cognitively normal elderly subjects: The Mayo Clinic study of aging
Molano, Jennifer Rose V. , Roberts, Rosebud O., Geda, Yonas V., Knopman, David S. , Tangalos, Eric G., Ivnik, Robert J., Cha, Ruth, Silber, Michael H. , Petersen, Ronald C. , Boeve, Bradley F. , Smith, Glenn E. , Pankratz, V. Shane , Ferman, Tanis J.

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_12 | Pages: No page available

10.1016/j.jalz.2008.05.1181 Get It

O1‐01–07: Frequency and clinical correlates of parkinsonism in the community‐dwelling elderly: The Mayo Clinic study of aging
Molano, Jennifer Rose V. , Mihçi, Ebru, Roberts, Rosebud O., Knopman, David S. , Tangalos, Eric G., Ivnik, Robert J., Cha, Ruth, Petersen, Ronald C. , Boeve, Bradley F. , Geda, Yonas E. , Smith, Glenn E. , Pankratz, V. Shane

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2008.05.217 Get It

A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains
Spilman, Patricia , Lessard, Pierre, Sattavat, Mamta, Bush, Clarissa, Tousseyn, Thomas , Huang, Eric J. , Giles, Kurt, Golde, Todd E. , Das, Pritam , Fauq, Abdul H. , Prusiner, Stanley B. , DeArmond, Stephen J.

Mayo Clinic

Proceedings of the National Academy of Sciences | July 22, 2008 | Volume: 105 | Issue: 30 | Pages: 10595-10600

10.1073/pnas.0803671105 | PMID 18647832 Get It

In prion-infected mice, both the Notch-1 intracellular domain transcription factor (NICD) and the disease-causing prion protein (PrP Sc ) increase in the brain preceding dendritic atrophy and loss. Because the drug LY411575 inhibits the γ-secretase-catalyzed cleavage of Notch-1 that produces NICD, we asked whether this γ-secretase inhibitor (GSI) might prevent dendritic degeneration in mice with scrapie. At 50 d postinoculation with Rocky Mountain Laboratory (RML) prions, mice were given GSI orally for 43–60 d. Because we did not expect GSI to produce a reduction of PrP Sc levels in brain, we added quinacrine (Qa) to the treatment regimen. Qa inhibits PrP Sc formation in cultured cells. The combination of GSI and Qa reduced PrP Sc by ≈95% in the neocortex and hippocampus but only ≈50% in the thalamus at the site of prion inoculation. The GSI plus Qa combination prevented dendritic atrophy and loss, but GSI alone did not. Even though GSI reduced NICD levels to a greater extent than GSI plus Qa, it was unable to prevent dendritic degeneration. Whether a balance between NICD and dendrite growth-stimulating factors was achieved with GSI plus Qa but not GSI alone remains to be determined. Although the combination of GSI and Qa diminished PrP Sc in the brains of RML-infected mice, GSI toxicity prevented us from being able to assess the effect the GSI plus Qa combination on incubation times. Whether less toxic GSIs can be used in place of LY411575 to prolong survival remains to be determined.
Translating Research Into Practice for Healthcare Providers
Bonow, Robert O. , Masoudi, Frederick A. , Fonarow, Gregg C. , Smith, Sidney C. , Solis, Penelope, Girgus, Meighan, Hinton, Patricia, Leonard, Anné , Gibbons, Raymond J. , Jones, Daniel W. , Peterson, Eric D.

Mayo Clinic

Circulation | July 15, 2008 | Volume: 118 | Issue: 6 | Pages: 687-696

10.1161/circulationaha.108.189934 | PMID 18625892 Get It

The American Heart Association’s (AHA’s) mission is “to build healthier lives, free of cardiovascular diseases and stroke.” This first article in a 2-part series will serve to present an overview of the work the AHA has undertaken to translate evidence into practice for healthcare professionals. It describes the extensive work of the AHA to support and further the delivery of evidence-based medicine, which includes the following: (1) supporting scientific discovery and the next generation of healthcare professionals and researchers; (2) disseminating scientific information; (3) developing evidence-based guidelines and statements; (4) creating and advocating for the implementation of performance indicators/measures; (5) developing clinical decision support and quality improvement tools; and (6) developing directed-cause campaigns, all of which can lead to improved patient care. This article also discusses the need for novel approaches and some of the AHA’s evolving strategies to help address gaps in care. The second article, which will be published shortly after this one, will examine the AHA’s efforts to engage and empower healthcare consumers to become more involved with their own health and health care.
Opioid-Induced Pain
Prommer, Eric

Mayo Clinic

Journal of Clinical Oncology | July 9, 2008 | Volume: 26 | Issue: 20 | Pages: 3464-3465

10.1200/jco.2008.17.3633 | PMID 18612166 Get It

Genomic Association Analysis Suggests Chromosome 12 Locus Influencing Antihypertensive Response to Thiazide Diuretic
Bailey, Kent R. , Chapman, Arlene B. , Schwartz, Gary L. , Chai, High Seng, Sicotte, Hugues , Kocher, Jean‐Pierre , Rodin, Andréi S. , Boerwinkle, Eric , Turner, Stephen T. , Fridley, Brooke L. , Chapman, Arlene B.

Mayo Clinic

Hypertension | July 1, 2008 | Volume: 52 | Issue: 2 | Pages: 359-365

10.1161/hypertensionaha.107.104273 | PMID 18591461 Get It

We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used to measure single nucleotide polymorphisms across the 22 autosomes in 194 non-Hispanic black subjects and 195 non-Hispanic white subjects with essential hypertension selected from opposite tertiles of the race- and sex-specific distributions of age-adjusted diastolic BP response to hydrochlorothiazide (25 mg daily, PO, for 4 weeks). The black sample consisted of 97 “good” responders (diastolic BP response [mean±SD]=−18.3±4.2 mm Hg; age=47.1±6.1 years; 51.5% women) and 97 “poor” responders (diastolic BP response=−0.18±4.3; age=47.4±6.5 years; 51.5% women). Haplotype trend regression identified a region of chromosome 12q15 in which haplotypes constructed from 3 successive single nucleotide polymorphisms (rs317689, rs315135, and rs7297610) in proximity to lysozyme ( LYZ ), YEATS domain containing 4 ( YEATS4 ), and fibroblast growth receptor substrate 2 ( FRS2 ) were significantly associated with diastolic BP response (nominal P =2.39×10 −7 ; Bonferroni corrected P =0.024; simulated experiment-wise P =0.040). Genotyping of 35 additional single nucleotide polymorphisms selected to “tag” linkage disequilibrium blocks in these genes provided corroboration that variation in LYZ and YEATS4 was associated with diastolic BP response in a statistically independent data set of 291 black subjects and in the sample of 294 white subjects. These results support the use of genome-wide association analyses to identify novel genes influencing antihypertensive drug responses.
Glutathione S -Transferase P1: Gene Sequence Variation and Functional Genomic Studies
Moyer, Ann M. , Salavaggione, Oreste E., Wu, Tse‐Yu, Moon, Irene, Eckloff, Bruce W., Schaid, Daniel J. , Wieben, Eric D. , Weinshilboum, Richard M. , Hildebrandt, Michelle A.T. , Weinshilboum, Richard M.

Mayo Clinic

Cancer Research | June 16, 2008 | Volume: 68 | Issue: 12 | Pages: 4791-4801

10.1158/0008-5472.can-07-6724 | PMID 18559526 Get It

Abstract Glutathione S-transferase P1 (GSTP1) is of importance for cancer research because of its role in detoxifying carcinogens, activating antineoplastic prodrugs, metabolizing chemotherapeutic agents, and its involvement in cell cycle and apoptosis regulation. Two common GSTP1 genetic polymorphisms have been studied extensively. However, the full range of GSTP1 genetic variation has not been systematically characterized in the absence of disease pathology. We set out to identify common GSTP1 polymorphisms in four ethnic groups, followed by functional genomic studies. All exons, splice junctions, and the 5′-flanking region of GSTP1 were resequenced using 60 DNA samples each from four ethnic groups. The 35 single-nucleotide polymorphisms (SNP) identified included six nonsynonymous SNPs and 17 previously unreported polymorphisms. GSTP1 variant allozymes were then expressed in COS-1 cells, and five displayed significantly altered levels of enzyme activity. One decreased to 22% of the wild-type (WT) activity. Four variant allozymes had Km values that differed significantly from that of the WT, and five showed altered levels of immunoreactive protein compared with WT, with a significant correlation (r = 0.79, P < 0.007) between levels of immunoreactive protein and enzyme activity in these samples. In the Mexican American population, five linked SNPs were significantly associated with GSTP1 mRNA expression, one of which was found by electrophoretic mobility shift assay to alter protein binding. These studies have identified functionally significant genetic variation, in addition to the two frequently studied GSTP1 nonsynonymous SNPs, that may influence GSTP1's contribution to carcinogen and drug metabolism, and possibly disease pathogenesis and/or drug response. [Cancer Res 2008;68(12):4791–801]
The Zebrafish Secretome
Klee, Eric W.

Mayo Clinic

Zebrafish | June 15, 2008 | Volume: 5 | Issue: 2 | Pages: 131-138

10.1089/zeb.2008.0529 | PMID 18554177 Get It

Osteoporosis in Men
Khosla, Sundeep , Amin, Shreyasee , Orwoll, Eric , Khosla, Sundeep , Orwoll, Eric S

Mayo Clinic

Endocrine Reviews | June 11, 2008 | Volume: 29 | Issue: 4 | Pages: 441-464

10.1210/er.2008-0002 | PMID 18451258 Get It